Scientists have discovered that bacteria within tumours produce 2-methylisocitrate (2-MiCit), a molecule that weakens cancer cells and enhances chemotherapy. Tested in worms, flies, and human cells, 2-MiCit disrupts cancer cell metabolism and DNA, improving drug effectiveness. This breakthrough opens new avenues for personalised cancer therapies.